H.R. 2430 - FDA Reauthorization Act of 2017

Health. 115th Congress (2017-2018) View bill details
Sponsor:
Summary:
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes. (by CRS) 
Status:
The bill has become law. 
Amendments:
3 proposed amendments. View amendments 
Senate Vote: On Passage

PASSED on August 3, 2017.

1/2 required to pass

voted YES: 94 voted NO: 1
5 voted present/not voting

FDA Reauthorization Act of 2017

H.R. 2430 — 115th Congress (2017–2018)

Summary
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes. (by CRS)
Learn More
At OpenCongress
Title
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
Other Titles
  • FDA Reauthorization Act of 2017
  • Biosimilar User Fee Amendments of 2017
  • Generic Drug User Fee Amendments of 2017
  • Medical Device User Fee Amendments of 2017
  • Prescription Drug User Fee Amendments of 2017
  • FDA Reauthorization Act of 2017
  • FDA Reauthorization Act of 2017
  • Biosimilar User Fee Amendments of 2017
  • Biosimilar User Fee Amendments of 2017
  • Generic Drug User Fee Amendments of 2017
  • Generic Drug User Fee Amendments of 2017
  • Medical Device User Fee Amendments of 2017
  • Medical Device User Fee Amendments of 2017
  • Prescription Drug User Fee Amendments of 2017
  • Prescription Drug User Fee Amendments of 2017
  • FDA Reauthorization Act of 2017
  • FDA Reauthorization Act of 2017
  • Biosimilar User Fee Amendments of 2017
  • Biosimilar User Fee Amendments of 2017
  • Generic Drug User Fee Amendments of 2017
  • Generic Drug User Fee Amendments of 2017
  • Medical Device User Fee Amendments of 2017
  • Medical Device User Fee Amendments of 2017
  • Prescription Drug User Fee Amendments of 2017
  • Prescription Drug User Fee Amendments of 2017
  • FDA Reauthorization Act of 2017
  • Biosimilar User Fee Amendments of 2017
  • Generic Drug User Fee Amendments of 2017
  • Medical Device User Fee Amendments of 2017
  • Prescription Drug User Fee Amendments of 2017
  • FDA Reauthorization Act of 2017
  • Biosimilar User Fee Amendments of 2017
  • Generic Drug User Fee Amendments of 2017
  • Medical Device User Fee Amendments of 2017
  • Prescription Drug User Fee Amendments of 2017
  • FDA Reauthorization Act of 2017
Sponsor
Greg Walden
Co-Sponsors
Subjects
  • Health
  • Administrative law and regulatory procedures
  • Cancer
  • Child health
  • Congressional oversight
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Drug therapy
  • Executive agency funding and structure
  • Food and Drug Administration (FDA)
  • Fraud offenses and financial crimes
  • Government buildings, facilities, and property
  • Government information and archives
  • Government studies and investigations
  • Health information and medical records
  • Health personnel
  • Health technology, devices, supplies
  • Hearing, speech, and vision care
  • Infectious and parasitic diseases
  • Licensing and registrations
  • Manufacturing
  • Marketing and advertising
  • Medical research
  • Medical tests and diagnostic methods
  • Performance measurement
  • Prescription drugs
  • Public-private cooperation
  • Small business
  • User charges and fees
Related Bills
Major Actions
Introduced5/16/2017
Referred to Committee
Amendments (3 proposed)
House7/12/2017
Passed Senate8/03/2017
Signed by President8/18/2017
Bill History
Chamber/CommitteeMotionDateResult
select this voteHouseOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.7/12/2017 by voice vote
select this voteSenateMotion to Invoke Cloture: Re: Motion to Proceed to Consideration of H.R. 24308/03/2017This motion PASSED the Senate
96 voted YES 1 voted NO 3 voted present/not voting
currently selectedSenateOn Passage of the Bill H.R. 24308/03/2017This bill PASSED the Senate
94 voted YES 1 voted NO 5 voted present/not voting
ActionDateDescription
Introduced5/16/2017
5/16/2017Introduced in House
5/16/2017Referred to the House Committee on Energy and Commerce.
5/16/2017Referred to the Subcommittee on Health.
5/18/2017Subcommittee Consideration and Mark-up Session Held.
5/18/2017Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
6/07/2017Committee Consideration and Mark-up Session Held.
Put on a legislative calendar6/07/2017Ordered to be Reported (Amended) by the Yeas and Nays: 54 - 0.
7/11/2017Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-201.
Put on a legislative calendar7/11/2017Placed on the Union Calendar, Calendar No. 138.
7/12/2017Mr. Walden moved to suspend the rules and pass the bill, as amended.
7/12/2017Considered under suspension of the rules.
7/12/2017DEBATE - The House proceeded with forty minutes of debate on H.R. 2430.
select this voteHouse Vote on Passage7/12/2017On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
7/12/2017Motion to reconsider laid on the table Agreed to without objection.
7/13/2017Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Put on a legislative calendar7/17/2017Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 174.
8/01/2017Motion to proceed to consideration of measure made in Senate.
8/01/2017Cloture motion on the motion to proceed to the measure presented in Senate.
8/02/2017
8/02/2017Senate amendment submitted
8/03/2017
8/03/2017Senate amendment submitted
8/03/2017
8/03/2017Senate amendment submitted
8/03/2017Motion to proceed to consideration of measure agreed to in Senate by Unanimous Consent.
8/03/2017Measure laid before Senate by motion.
8/03/2017Message on Senate action sent to the House.
8/03/2017Motion to proceed to measure considered in Senate.
select this voteVote8/03/2017Motion to Invoke Cloture: Re: Motion to Proceed to Consideration of H.R. 2430
currently selectedSenate Vote on Passage8/03/2017On Passage of the Bill H.R. 2430
Presented to President8/07/2017Presented to President.
Signed8/18/2017Signed by President.
Enacted8/18/2017Became Public Law No: 115-52.
NumberSponsorDate OfferedStatus
S. Amdt. 751Reed, John [D-RI]August 2, 2017Offered on August 1, 2017.

Show amendment details

S. Amdt. 754Merkley, Jeff [D-OR]August 3, 2017Offered on August 2, 2017.

Show amendment details

S. Amdt. 755Merkley, Jeff [D-OR]August 3, 2017Offered on August 2, 2017.

Show amendment details

Average contributions given to Senators from interest groups that…

support this bill

62 times as much
$13,443
$18,471
$5,680
$84,651
$6,597
$145,108
$15,441
$3,631
$43,645
$15,168
$24,132
$6,672
$14,677
$1,987
$113
$8,439
$18,685
$3,571
$39,863
YES$469,975
$125
$0
$1,000
$250
$500
$1,000
$225
$0
$0
$0
$2,400
$0
$850
$0
$0
$250
$250
$0
$750
NO$7,600

oppose this bill

Physicians
Average given to Senators who voted:
$98,365
YES$98,365
73% less
$26,874
NO$26,874
33 Organizations Support and 1 Opposes; See Which Ones

Organizations that took a position on
FDA Reauthorization Act of 2017: On Passage of the Bill H.R. 2430

33 organizations support this bill

Aetna
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
America's Business Benefit Association
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
American Academy of Ophthalmology
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
American Cancer Society Cancer Action Network
ACSCAN (2017, July 12). House Passage of FDA User Fee Reauthorization Makes Cancer Patients a Priority. Retrieved July 13, 2017, from American Cancer Society.
Association for Accessible Medicines
AAM (2017, August 3). AAM Statement on Senate Passage of FDA User Fee Reauthorization (FDARA). Retrieved September 8, 2017, from AAM.
Biocom
Biocom (2017, July 12). Biocom Applauds Passage of FDA Reauthorization Act. Retrieved July 12, 2017, from PR Newswire.
Biotechnology Industry Organization
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
Bipartisan Policy Center
Bipartisan Policy Center (2017, August 3). Passage of FDA Reauthorization Act is Important Milestone for Patients. Retrieved September 6, 2017, from Bipartisan Policy Center.
California Life Sciences Association
CLSA (2017, August 3). U.S. Senate Approves Measure to Support Operations at the FDA to Help Propel Bioscience & MedTech Investment and Innovation. Retrieved September 8, 2017, from CLSA.
Cigna
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
Council for Affordable Health Coverage
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
CVS Health
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
Express Scripts
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
GlaxoSmithKline
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
Healthcare Leadership Council
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
Healthcare Supply Chain Association
HSCA (2017, August 21). HSCA Applauds President Trump for Signing FDA Reauthorization Act. Retrieved September 8, 2017, from HSCA.
Healthcare.com
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
HealthSherpa
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
International Franchise Association
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
IntriCon
IntriCon (2017, August 3). IntriCon Supports U.S. Senate Passing FDA Reauthorization Act. Retrieved September 8, 2017, from Intricon.
Latino Coalition
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
National Association for the Self-Employed
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
National Association of Manufacturers
Boerstling, Robyn (2017, June 7). Protect Innovation and the Advancement of New Medicines. Retrieved June 8, 2017, from National Association of Manufacturers.
National Grange
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
National Health Council
NHC (2017, July 12). NHC and NORD Commend House Passage of FDA User Fee Reauthorization; Urge Senate to Follow Suit. Retrieved September 6, 2017, from NHC.
National Organization for Rare Disorders
NHC (2017, July 12). NHC and NORD Commend House Passage of FDA User Fee Reauthorization; Urge Senate to Follow Suit. Retrieved September 6, 2017, from NHC.
National Patient Advocate Foundation
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
National Retail Federation
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
Pharmaceutical Care Management Association
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
Small Business & Entrepreneurship Council
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
Society for Women's Health Research
SWHR (2017, August 21). SWHR Lauds Passage and Signage of FDA Reauthorization Act of 2017 into Law. Retrieved September 6, 2017, from Society for Women's Health Research.
U.S. Chamber of Commerce
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.
WEX Health
Council for Affordable Health Coverage (2017, August 3). CAHC Praises Senate Passage of FDA Reauthorization Act. Retrieved September 6, 2017, from Council for Affordable Health Coverage.

1 organization oppose this bill

American Academy of Pediatrics
Stein, Fernando (2017, August 3). AAP Statement on Senate Passage of the FDA Reauthorization Act of 2017. Retrieved September 8, 2017, from AAP.

Need proof?

View citations of support and opposition

Includes reported contributions to congressional campaigns of Senators in office on day of vote, from interest groups invested in the vote according to MapLight, November 29, 2010 – November 28, 2016.
Contributions data source: OpenSecrets.org

Contributions by Legislator

Namesort iconPartyState$ From Interest Groups
That Support
$ From Interest Groups
That Oppose
Vote
Andrew Lamar AlexanderRTN$564,778$35,800Yes
Tammy BaldwinDWI$1,103,997$104,132Yes
John BarrassoRWY$344,883$191,000Yes
Michael F. BennetDCO$620,525$112,296Yes
Richard BlumenthalDCT$283,300$66,900Yes
Roy BluntRMO$669,497$137,200Yes
Cory A. BookerDNJ$535,745$98,396Yes
John BoozmanRAR$153,100$74,215Yes
Sherrod BrownDOH$766,413$208,132Yes
Richard BurrRNC$710,410$116,275Not Voting
Maria CantwellDWA$199,744$58,015Yes
Shelley Moore CapitoRWV$239,940$103,200Yes
Ben CardinDMD$288,402$67,410Yes
Tom CarperDDE$324,510$19,750Yes
Bob CaseyDPA$768,542$96,292Yes
Bill CassidyRLA$600,876$547,270Yes
William Thad CochranRMS$223,712$24,650Yes
Susan M. CollinsRME$250,100$38,450Yes
Christopher A. CoonsDDE$302,900$27,250Yes
Bob CorkerRTN$439,639$146,706Yes
John CornynRTX$535,655$366,041Yes
Catherine Cortez MastoDNV$2,010,478$129,946Yes
Tom CottonRAR$135,744$158,468Yes
Mike CrapoRID$276,850$40,092Yes
Ted CruzRTX$213,684$196,520Yes
Steve DainesRMT$158,466$28,785Yes
Joe DonnellyDIN$321,332$58,785Yes
Tammy DuckworthDIL$2,106,904$106,986Yes
Dick DurbinDIL$286,410$74,835Yes
Mike EnziRWY$333,550$34,750Yes
Joni ErnstRIA$82,549$11,500Yes
Dianne FeinsteinDCA$428,809$75,976Yes
Deb FischerRNE$180,091$44,785Yes
Jeff FlakeRAZ$262,964$51,700Yes
Al FrankenDMN$191,939$60,692Yes
Cory GardnerRCO$382,890$61,375Yes
Kirsten E. GillibrandDNY$853,060$103,826Yes
Lindsey GrahamRSC$238,090$80,442Yes
Chuck GrassleyRIA$301,460$97,200Yes
Kamala D. HarrisDCA$998,794$75,857Yes
Margaret Wood HassanDNH$1,566,439$45,449Yes
Orrin G. HatchRUT$1,002,258$93,950Yes
Martin HeinrichDNM$229,503$61,950Yes
Heidi HeitkampDND$329,016$30,783Yes
Dean HellerRNV$248,845$113,045Yes
Mazie K. HironoDHI$506,182$42,350Yes
John HoevenRND$92,610$16,800Not Voting
Jim InhofeROK$78,350$25,100Not Voting
Johnny IsaksonRGA$498,000$65,150Not Voting
Ron JohnsonRWI$238,875$105,820Yes
Tim KaineDVA$661,614$125,201Yes
John KennedyRLA$77,000$52,550Yes
Angus S. King, Jr.IME$94,517$27,200Yes
Amy KlobucharDMN$611,703$31,350Yes
James LankfordROK$187,326$77,825Yes
Patrick J. LeahyDVT$112,850$21,500Yes
Mike LeeRUT$144,077$23,275Yes
Joe Manchin, IIIDWV$280,550$45,600Yes
Ed MarkeyDMA$430,348$87,200Yes
John McCainRAZ$211,003$58,755Not Voting
Claire McCaskillDMO$1,487,095$115,978Yes
Addison "Mitch" McConnellRKY$1,085,649$442,700Yes
Bob MenéndezDNJ$489,203$416,750Yes
Jeff MerkleyDOR$105,103$40,184Yes
Jerry MoranRKS$208,225$25,500Yes
Lisa MurkowskiRAK$151,368$35,200Yes
Chris MurphyDCT$225,471$128,744Yes
Patty MurrayDWA$1,124,612$72,110Yes
Clarence "Bill" NelsonDFL$306,657$210,700Yes
Rand PaulRKY$222,051$187,067Yes
David PerdueRGA$258,349$64,590Yes
Gary C. PetersDMI$648,398$250,260Yes
Rob PortmanROH$832,410$120,630Yes
John "Jack" ReedDRI$92,463$23,500Yes
Jim RischRID$72,150$4,000Yes
Charles "Pat" RobertsRKS$439,613$66,200Yes
Mike RoundsRSD$179,929$52,800Yes
Marco RubioRFL$322,579$166,885Yes
Bernie SandersIVT$7,600$26,874No
Ben SasseRNE$260,245$53,797Yes
Brian SchatzDHI$141,525$45,050Yes
Chuck SchumerDNY$828,051$129,188Yes
Tim ScottRSC$752,227$143,680Yes
Jeanne ShaheenDNH$1,039,826$47,140Yes
Richard C. ShelbyRAL$77,800$0Yes
Debbie StabenowDMI$730,193$128,248Yes
Luther StrangeRAL$0$0Yes
Dan SullivanRAK$99,060$68,550Yes
Jon TesterDMT$422,814$70,025Yes
John ThuneRSD$252,376$44,125Yes
Thom TillisRNC$219,102$120,550Yes
Patrick J. ToomeyRPA$887,121$146,246Yes
Tom UdallDNM$113,275$79,770Yes
Chris Van HollenDMD$527,349$206,320Yes
Mark R. WarnerDVA$382,775$75,400Yes
Elizabeth WarrenDMA$1,856,915$214,743Yes
Sheldon WhitehouseDRI$218,503$32,525Yes
Roger F. WickerRMS$93,408$25,950Yes
Ron WydenDOR$803,827$77,145Yes
Todd YoungRIN$518,517$113,350Yes

Add Data Filters:

Legislator Filters
Legislator Filters
NamePartyState$ From Interest Groups
That Support
$ From Interest Groups
That Oppose
Vote
Andrew Lamar AlexanderRTN$564,778$35,800Yes
Tammy BaldwinDWI$1,103,997$104,132Yes
John BarrassoRWY$344,883$191,000Yes
Michael F. BennetDCO$620,525$112,296Yes
Richard BlumenthalDCT$283,300$66,900Yes
Roy BluntRMO$669,497$137,200Yes
Cory A. BookerDNJ$535,745$98,396Yes
John BoozmanRAR$153,100$74,215Yes
Sherrod BrownDOH$766,413$208,132Yes
Richard BurrRNC$710,410$116,275Not Voting
Maria CantwellDWA$199,744$58,015Yes
Shelley Moore CapitoRWV$239,940$103,200Yes
Ben CardinDMD$288,402$67,410Yes
Tom CarperDDE$324,510$19,750Yes
Bob CaseyDPA$768,542$96,292Yes
Bill CassidyRLA$600,876$547,270Yes
William Thad CochranRMS$223,712$24,650Yes
Susan M. CollinsRME$250,100$38,450Yes
Christopher A. CoonsDDE$302,900$27,250Yes
Bob CorkerRTN$439,639$146,706Yes
John CornynRTX$535,655$366,041Yes
Catherine Cortez MastoDNV$2,010,478$129,946Yes
Tom CottonRAR$135,744$158,468Yes
Mike CrapoRID$276,850$40,092Yes
Ted CruzRTX$213,684$196,520Yes
Steve DainesRMT$158,466$28,785Yes
Joe DonnellyDIN$321,332$58,785Yes
Tammy DuckworthDIL$2,106,904$106,986Yes
Dick DurbinDIL$286,410$74,835Yes
Mike EnziRWY$333,550$34,750Yes
Joni ErnstRIA$82,549$11,500Yes
Dianne FeinsteinDCA$428,809$75,976Yes
Deb FischerRNE$180,091$44,785Yes
Jeff FlakeRAZ$262,964$51,700Yes
Al FrankenDMN$191,939$60,692Yes
Cory GardnerRCO$382,890$61,375Yes
Kirsten E. GillibrandDNY$853,060$103,826Yes
Lindsey GrahamRSC$238,090$80,442Yes
Chuck GrassleyRIA$301,460$97,200Yes
Kamala D. HarrisDCA$998,794$75,857Yes
Margaret Wood HassanDNH$1,566,439$45,449Yes
Orrin G. HatchRUT$1,002,258$93,950Yes
Martin HeinrichDNM$229,503$61,950Yes
Heidi HeitkampDND$329,016$30,783Yes
Dean HellerRNV$248,845$113,045Yes
Mazie K. HironoDHI$506,182$42,350Yes
John HoevenRND$92,610$16,800Not Voting
Jim InhofeROK$78,350$25,100Not Voting
Johnny IsaksonRGA$498,000$65,150Not Voting
Ron JohnsonRWI$238,875$105,820Yes
Tim KaineDVA$661,614$125,201Yes
John KennedyRLA$77,000$52,550Yes
Angus S. King, Jr.IME$94,517$27,200Yes
Amy KlobucharDMN$611,703$31,350Yes
James LankfordROK$187,326$77,825Yes
Patrick J. LeahyDVT$112,850$21,500Yes
Mike LeeRUT$144,077$23,275Yes
Joe Manchin, IIIDWV$280,550$45,600Yes
Ed MarkeyDMA$430,348$87,200Yes
John McCainRAZ$211,003$58,755Not Voting
Claire McCaskillDMO$1,487,095$115,978Yes
Addison "Mitch" McConnellRKY$1,085,649$442,700Yes
Bob MenéndezDNJ$489,203$416,750Yes
Jeff MerkleyDOR$105,103$40,184Yes
Jerry MoranRKS$208,225$25,500Yes
Lisa MurkowskiRAK$151,368$35,200Yes
Chris MurphyDCT$225,471$128,744Yes
Patty MurrayDWA$1,124,612$72,110Yes
Clarence "Bill" NelsonDFL$306,657$210,700Yes
Rand PaulRKY$222,051$187,067Yes
David PerdueRGA$258,349$64,590Yes
Gary C. PetersDMI$648,398$250,260Yes
Rob PortmanROH$832,410$120,630Yes
John "Jack" ReedDRI$92,463$23,500Yes
Jim RischRID$72,150$4,000Yes
Charles "Pat" RobertsRKS$439,613$66,200Yes
Mike RoundsRSD$179,929$52,800Yes
Marco RubioRFL$322,579$166,885Yes
Bernie SandersIVT$7,600$26,874No
Ben SasseRNE$260,245$53,797Yes
Brian SchatzDHI$141,525$45,050Yes
Chuck SchumerDNY$828,051$129,188Yes
Tim ScottRSC$752,227$143,680Yes
Jeanne ShaheenDNH$1,039,826$47,140Yes
Richard C. ShelbyRAL$77,800$0Yes
Debbie StabenowDMI$730,193$128,248Yes
Luther StrangeRAL$0$0Yes
Dan SullivanRAK$99,060$68,550Yes
Jon TesterDMT$422,814$70,025Yes
John ThuneRSD$252,376$44,125Yes
Thom TillisRNC$219,102$120,550Yes
Patrick J. ToomeyRPA$887,121$146,246Yes
Tom UdallDNM$113,275$79,770Yes
Chris Van HollenDMD$527,349$206,320Yes
Mark R. WarnerDVA$382,775$75,400Yes
Elizabeth WarrenDMA$1,856,915$214,743Yes
Sheldon WhitehouseDRI$218,503$32,525Yes
Roger F. WickerRMS$93,408$25,950Yes
Ron WydenDOR$803,827$77,145Yes
Todd YoungRIN$518,517$113,350Yes

Interest Groups that support this bill

$ Donated
Women's issues$13,641,171
Pharmaceutical manufacturing$8,438,574
Accident & health insurance$4,316,756
Medical Devices & Supplies$3,947,798
Health care services$2,332,643
Biotech products & research$1,875,610
Pharmaceutical wholesale$1,835,049
Optometrists & Ophthalmologists$1,496,898
Drug stores$1,492,124
Minority/Ethnic Groups$1,423,851
Health, Education & Human Resources$1,301,811
Retail trade$845,279
General business associations$660,023
Health & welfare policy$632,146
Manufacturing$592,718
Small business associations$377,819
Chambers of commerce$362,426
Agriculture$192,286
Consumer groups$10,650

Interest Groups that oppose this bill

$ Donated
Physicians$9,555,227
Loading…
Date Range of Contributions
Enter a custom date range